# Canopy Growth Corporation

> Canopy Growth is a Smiths Falls, Ontario cannabis company selling medical and adult-use cannabis in Canada and overseas, plus Storz & Bickel vaporizers worldwide. Once the industry's most lavish expansion story, it has spent years closing facilities, cutting costs and simplifying its portfolio. Its latest bet is more practical: use the 2026 acquisition of MTL Cannabis to improve flower quality, strengthen its medical channel and make its Canadian-to-European supply chain earn its keep.

- **Founded:** 2013
- **Headquarters:** Smiths Falls, Canada
- **Founders:** Bruce Linton (Co-founder and former Chairman and Co-CEO), Chuck Rifici (Co-founder and first CEO of Tweed), Mark Zekulin (Early co-founder and former President and Co-CEO)
- **Team size:** Approximately 1,200 employees based on supplied company data; LinkedIn lists 1,001-5,000
- **Products:** Canadian adult-use cannabis, Medical cannabis and clinics, Storz & Bickel vaporizers, International medical cannabis, Canopy USA exposure
- **Notable:** Became the first federally regulated, licensed cannabis producer to trade publicly in North America., Became the first cannabis producer listed on the New York Stock Exchange in May 2018 before later moving its U.S. listing to Nasdaq., Made Canada's first legal recreational cannabis sale at midnight on October 17, 2018 through co-founder Bruce Linton.

## Products & services

- **Canadian adult-use cannabis** — Flower, pre-rolls, infused pre-rolls, vapes, oils, softgels and edibles sold under brands including Tweed, 7ACRES, DOJA, Claybourne, Deep Space, DeeLish and MTL Cannabis.
- **Medical cannabis and clinics** — Patient products and services through Spectrum Therapeutics, Apollo Cannabis Clinics, Canada House Clinics and Abba Medix, including insured and veteran customers.
- **Storz & Bickel vaporizers** — German-engineered devices and accessories including VOLCANO, VENTY, VEAZY, MIGHTY+, CRAFTY+ and medical-device variants.
- **International medical cannabis** — Canadian-grown and third-party cannabis supplied to regulated medical markets, particularly Germany and Poland, through EU GMP-certified cultivation, packaging and distribution.
- **Canopy USA exposure** — A non-controlling interest providing economic exposure to a U.S. platform that owns Acreage, Wana and a majority stake in Jetty; Canopy Growth does not control or consolidate it.

## Achievements

- Became the first federally regulated, licensed cannabis producer to trade publicly in North America.
- Became the first cannabis producer listed on the New York Stock Exchange in May 2018 before later moving its U.S. listing to Nasdaq.
- Made Canada's first legal recreational cannabis sale at midnight on October 17, 2018 through co-founder Bruce Linton.
- Built a Canadian medical platform that the company says became the country's largest by revenue after acquiring MTL Cannabis in March 2026.
- Renewed EU GMP certification at its Kincardine, Ontario facility in August 2026, preserving a Canadian-grown medical supply route into Europe.
- Claybourne Frosted Flyers won Best Infused Pre-Roll at the 2026 Grow Up Awards.
- Apollo Cannabis Clinics won Best Medical Cannabis Clinic in the 2025 Toronto Star Readers' Choice Awards.
- Improved to the number-six position in Canada's adult-use market in Q1 FY2027, according to company-cited market data.

## Latest updates

- **2026-08** — Reported Q1 FY2027 net revenue of C$81.2 million, up 13% year over year, with adjusted EBITDA loss narrowing 59% to C$3.2 million.
- **2026-08** — Renewed EU GMP certification at the Kincardine cultivation facility, allowing continued supply of Canadian-grown medical cannabis to Europe.
- **2026-08** — Unveiled a refreshed corporate identity and brandmark focused on medical, wellness and adult-use cannabis.
- **2026-06** — Reported FY2026 revenue of C$284.6 million, a C$20.2 million adjusted EBITDA loss and C$69.1 million in free cash outflow.
- **2026-05** — Restated prior financial statements after identifying a technical non-cash warrant-classification error.
- **2026-03** — Completed the approximately C$125 million equity-value acquisition of MTL Cannabis.
- **2026-01** — Completed a recapitalization that pushed major debt maturities to 2031 and helped produce a net cash position.

## Links

- Website: https://canopygrowth.com
- LinkedIn: https://www.linkedin.com/company/canopy-growth-corporation
- Twitter/X: https://x.com/CanopyGrowth
- Facebook: https://www.facebook.com/canopygrowth/

---

Profile page: https://yespress.io/canopy-growth-corporation
Published by YesPress — https://yespress.io
Last updated: 2026-08-23